|
1
|
Atlanta: Cancer Facts & Figures 2015.
American Cancer Society; 2015:
|
|
2
|
Henley SJ, Richards TB, Underwood JM,
Eheman CR, Plescia M, McAfee TA, et al: Centers for Disease Control
and Prevention (CDC): Lung cancer incidence trends among men and
women-United States, 2005–2009. MMWR Morb Mortal Wkly Rep. 63:1–5.
2014.PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liam CK, Andarini S, Lee P, Ho JC, Chau NQ
and Tscheikuna J: Lung cancer staging now and in the future.
Respirology. 20:526–34. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tsao AS and Papadimitrakopoulou V: The
importance of molecular profiling in predicting response to
epidermal growth factor receptor family inhibitors in
non-small-cell lung cancer: Focus on clinical trial results. Clin
Lung Cancer. 14:311–321. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Heinen TE and da Veiga AB: Arthropod
venoms and cancer. Toxicon. 57:497–511. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Song HS, Ko MS, Jo YS, Whang WK and Sim
SS: Inhibitory effect of acteoside on melittin-induced
catecholamine exocytosis through inhibition of Ca(2+)-dependent
phospholipase A2 and extracellular Ca(2+) influx in PC12 cells.
Arch Pharm Res. 38:1913–1920. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mulder KC, Lima LA, Miranda VJ, Dias SC
and Franco OL: Current scenario of peptide-based drugs: The key
roles of cationic antitumor and antiviral peptides. Front
Microbiol. 4:3212013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu S, Yu M, He Y, Xiao L, Wang F, Song C,
Sun S, Ling C and Xu Z: Melittin prevents liver cancer cell
metastasis through inhibition of the Rac1-dependent pathway.
Hepatology. 47:1964–1973. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Raghuraman H and Chattopadhyay A:
Melittin: A membrane-active peptide with diverse functions. Biosci
Rep. 27:189–223. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Orsolic N: Bee venom in cancer therapy.
Cancer Metastasis Rev. 31:173–194. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jeong YJ, Choi Y, Shin JM, Cho HJ, Kang
JH, Park KK, Choe JY, Bae YS, Han SM, Kim CH, et al: Melittin
suppresses EGF-induced cell motility and invasion by inhibiting
PI3K/Akt/mTOR signaling pathway in breast cancer cells. Food Chem
Toxicol. 68:218–225. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shin JM, Jeong YJ, Cho HJ, Park KK, Chung
IK, Lee IK, Kwak JY, Chang HW, Kim CH, Moon SK, et al: Melittin
suppresses HIF-1α/VEGF expression through inhibition of ERK and
mTOR/p70S6K pathway in human cervical carcinoma cells. PLoS One.
8:e693802013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Choi JY, Hong WG, Cho JH, Kim EM, Kim J,
Jung CH, Hwang SG, Um HD and Park JK: Podophyllotoxin acetate
triggers anticancer effects against non-small cell lung cancer
cells by promoting cell death via cell cycle arrest, ER stress and
autophagy. Int J Oncol. 47:1257–1265. 2015.PubMed/NCBI
|
|
15
|
Yang X, Zhu H, Ge Y, Liu J, Cai J, Qin Q,
Zhan L, Zhang C, Xu L, Liu Z, et al: Melittin enhances
radiosensitivity of hypoxic head and neck squamous cell carcinoma
by suppressing HIF-1α. Tumour Biol. 35:10443–10448. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Samarajeewa NU, Yang F, Docanto MM,
Sakurai M, McNamara KM, Sasano H, Fox SB, Simpson ER and Brown KA:
HIF-1α stimulates aromatase expression driven by prostaglandin E2
in breast adipose stroma. Breast Cancer Res. 15:R302013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schnabel PA and Junker K: Neuroendocrine
tumors of the lungs. From small cell lung carcinoma to diffuse
idiopathic pulmonary neuroendocrine cell hyperplasia. Pathologe.
35:557–564. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mahmood S, Bilal H, Faivre-Finn C and Shah
R: Is stereotactic ablative radiotherapy equivalent to sublobar
resection in high-risk surgical patients with stage I
non-small-cell lung cancer? Interact Cardiovasc Thorac Surg.
17:845–853. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mokdad AH, Dwyer-Lindgren L, Fitzmaurice
C, Stubbs RW, Bertozzi-Villa A, Morozoff C, Charara R, Allen C,
Naghavi M and Murray CJ: Trends and patterns of disparities in
cancer mortality among US counties, 1980–2014. JAMA. 317:388–406.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Spira A, Halmos B and Powell CA: Update in
lung cancer 2014. Am J Respir Crit Care Med. 192:283–294. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gajski G and Garaj-Vrhovac V: Melittin: A
lytic peptide with anticancer properties. Environ Toxicol
Pharmacol. 36:697–705. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gerst JE and Salomon Y: Inhibition by
melittin and fluphenazine of melanotropin receptor function and
adenylate cyclase in M2R melanoma cell membranes. Endocrinology.
121:1766–1772. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Duke RC, Witter RZ, Nash PB, Young JD and
Ojcius DM: Cytolysis mediated by ionophores and pore-forming
agents: Role of intracellular calcium in apoptosis. FASEB J.
8:237–246. 1994.PubMed/NCBI
|
|
24
|
Prager GW, Poettler M, Unseld M and
Zielinski CC: Angiogenesis in cancer: Anti-VEGF escape mechanisms.
Transl Lung Cancer Res. 1:14–25. 2012.PubMed/NCBI
|
|
25
|
Holle L, Song W, Holle E, Wei Y, Wagner T
and Yu X: A matrix metalloproteinase 2 cleavable melittin/avidin
conjugate specifically targets tumor cells in vitro and
in vivo. Int J Oncol. 22:93–98. 2003.PubMed/NCBI
|
|
26
|
Moon DO, Park SY, Heo MS, Kim KC, Park C,
Ko WS, Choi YH and Kim GY: Key regulators in bee venom-induced
apoptosis are Bcl-2 and caspase-3 in human leukemic U937 cells
through downregulation of ERK and Akt. Int Immunopharmacol.
6:1796–1807. 2006. View Article : Google Scholar : PubMed/NCBI
|
